Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Classical hematology 1

Conditions

Neoplasms 2Pain, Intractable 1Mucositis 1Leukemia 1Inflammatory Bowel Diseases 1Diverticulitis 1Diverticular Diseases 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Breast Cancer Female 1Breakthrough Pain 1Bone Marrow Failure Disorders 1Bites and Stings 1Anemia, Aplastic 1Agnosia 1Acute Pain 1

Interventions

fludarabine phosphate 7fludarabine 6Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 4Antilymphocyte Serum 4Alemtuzumab 3Thiotepa 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Clofarabine 2Bone Marrow Transplantation 2treosulfan 1thymoglobulin 1posaconazole 1eltrombopag 1X-Rays 1Therapeutics 1Specimen Handling 1Sirolimus 1Passive Cutaneous Anaphylaxis 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Methadone 1Hydromorphone 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Passive Cutaneous Anaphylaxis × Clear all
NCT06940570 2025-10-23

MATCH

University of Texas Southwestern Medical Center

Phase 3 Suspended
60 enrolled
Classical hematologyOtherOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Aplastic, Leukemia, Neoplasms, Pain, Intractable, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡